Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CI
CI logo

CI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
289.910
Open
286.530
VWAP
286.96
Vol
1.10M
Mkt Cap
74.59B
Low
284.340
Amount
314.42M
EV/EBITDA(TTM)
7.22
Total Shares
264.53M
EV
97.87B
EV/OCF(TTM)
11.11
P/S(TTM)
0.27
The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.
Show More

Events Timeline

(ET)
2026-06-23
11:00:00
Justice Department to Charge 450 Defendants in $6.5B Healthcare Fraud
select
link
2026-06-11 (ET)
2026-06-11
10:00:00
Employers Consider Reducing GLP-1 Weight Loss Drug Coverage
select
link
2026-05-20 (ET)
2026-05-20
11:50:00
Major Averages Rise as Semiconductor Stocks Rebound
select

News

Newsfilter
9.5
10:40 AMNewsfilter
PinnedCigna Group to Release Q2 2026 Financial Results
  • Earnings Release Schedule: The Cigna Group will release its Q2 2026 financial results on July 30, 2026, with results expected by 6:30 a.m. ET, followed by a management conference call at 8:30 a.m. to discuss financial performance.
  • Conference Call Details: Participants are advised to dial in by 8:15 a.m. ET on July 30, with domestic call-in numbers at (888) 566-1889 and international at (773) 799-3989, using passcode 07302026.
  • Replay Information: A replay of the conference call will be available from 12:30 p.m. ET on July 30 until 10:59 p.m. ET on August 13, with domestic replay at (866) 405-7290 and international at (203) 369-0603, ensuring investors can access the information at their convenience.
  • Webcast Availability: The conference call will also be available via live internet webcast on Cigna Group's investor relations website, although this feature will be in listen-only mode, allowing a broad range of investors to stay informed with the latest updates.
Fool
6.5
07-05Fool
Vanguard Research Bullish on U.S. Economic Outlook
  • GDP Growth Forecast: Vanguard's research projects a 3% growth in U.S. GDP by 2027, which is likely to positively impact U.S. stock markets, especially with core inflation expected to drop to 2.7%, potentially boosting bond prices.
  • Value Stock Investment Opportunity: The research highlights that U.S. value stocks could be a good investment choice, as these companies are positioned to benefit from AI productivity gains without incurring upfront costs for AI data centers and capital expenditures, thereby enhancing investor return potential.
  • Vanguard Value Factor ETF Performance: The Vanguard U.S. Value Factor ETF (VFVA) has seen a 28.1% increase over the past year and a 12.9% gain in the first half of 2023, underscoring its significance in a diversified portfolio, particularly with holdings across financials, consumer discretionary, and healthcare sectors.
  • Bond Market Outlook: The Vanguard Total Bond Market ETF (BND) has delivered an average annual return of 3.1% since its inception in 2007, despite only 0.1% over the past five years; however, if inflation and interest rates decline as projected, future bond investments could yield better returns.
NASDAQ.COM
8.5
07-05NASDAQ.COM
Vanguard Research Bullish on Value Stocks and Bonds
  • Value Stock Investment Opportunity: The Vanguard U.S. Value Factor ETF has outperformed the S&P 500 index with a 28.1% annual return over the past year, and its P/E ratio of 11 indicates a significant discount compared to the S&P 500's 25, suggesting that value stocks could be a good investment choice in the coming years.
  • Bond Market Outlook: Despite the Vanguard Total Bond Market ETF's average annual return of only 0.1% over the past five years, it has delivered an average annual return of 3.1% since its inception in 2007, indicating potential for long-term investment, especially as inflation and interest rates may decline.
  • Diversified Portfolio: The Vanguard U.S. Value Factor ETF holds a portfolio of 649 stocks across large-cap, mid-cap, and small-cap categories, with top sector holdings including financials (23.5%) and consumer discretionary (18.5%), ensuring broad diversification and reducing sector-specific risks.
  • Low Cost Advantage: The Vanguard Total Bond Market ETF features an ultra-low expense ratio of 0.03%, making it a cost-effective option in the bond ETF space, and its diversified portfolio of 11,455 bonds provides a solid yield potential, making it suitable for a long-term investor's diversified strategy.
CNBC
6.5
07-01CNBC
UBS Identifies Attractive Defensive Stock Opportunities
  • Market Concentration Analysis: According to UBS, the market experienced strong gains in the first half of the year, primarily driven by a handful of megacap tech companies, leading to historically low correlations across stocks, indicating that investors are avoiding lower-risk companies, which has made many defensive stocks attractive in valuation.
  • Valuation Gap in Defensive Stocks: Analyst Sean Burns highlighted that the gap between expensive and cheap defensive stocks is near the widest levels seen since 1990, nearly double the long-run average, with low-risk stocks trading at a market-implied yield of 4.4% compared to just 1.4% for high-risk stocks.
  • Quality Defensive Stock Screening: UBS screened for defensive stocks with a market cap of at least $5 billion and a negative correlation to the S&P 500 over the past year, finding that these stocks not only exhibit low volatility but are also trading at discounts, all rated as buys by UBS.
  • Individual Stock Performance Expectations: For instance, PepsiCo (PEP) is down about 6% year-to-date but is expected to report strong second-quarter earnings, with its North American food business recovering volume growth after price cuts; McDonald's (MCD) also beat first-quarter earnings expectations and is expected to continue gaining market share globally.
seekingalpha
8.5
07-01seekingalpha
Cigna Invests $100M in New Specialty Care Program
  • Program Launch: Cigna's health services division, Evernorth, launched a new specialty care program named Fast Forward with a $100M investment aimed at accelerating care delivery and improving patient outcomes, projected to generate approximately $400M in value by 2028.
  • Patient Reach: The program will initially roll out across Evernorth's Accredo Specialty Pharmacy, targeting over one million patients suffering from chronic and complex health conditions annually, showcasing its potential in enhancing patient care.
  • AI Integration: Fast Forward aims to leverage artificial intelligence across four key areas in the pharmacy value chain, with expectations to improve medication adherence above 80% and reduce clinician documentation time by up to 50%, thereby enhancing overall operational efficiency.
  • Strategic Commitment: Matt Perlberg, who leads Evernorth's pharmacy and care delivery operations, emphasized that the program reflects the company's commitment to delivering a faster, seamless experience while ensuring patients receive personalized support and clinical care.
PRnewswire
8.5
06-25PRnewswire
Cigna Launches New Military Service Grant
  • New Grant Launch: The Cigna Group Foundation has announced the launch of the $1.5 million 'Courage in Service' grant, aimed at supporting the health and well-being of military and veteran communities, reflecting the company's long-standing commitment to this demographic.
  • Annual Funding Program: Each year, $150,000 will be awarded to a nonprofit organization to support programs that strengthen social connections, improve well-being, and increase stability for military families navigating key life transitions.
  • CEO Retirement and Legacy: The grant's introduction coincides with David Cordani's retirement as CEO of The Cigna Group, transitioning to executive chair of the board, marking a continuation of his 17-year focus on supporting military communities.
  • Application Open and Timeline: Grant applications are now open until July 30, 2026, with funding expected to commence on January 1, 2027, further enhancing support for military and veteran communities.
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
Wall Street analysts forecast CI stock price to rise
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Barclays
Andrew Mok
Overweight
to
Equal Weight
downgrade
$310 -> $304
AI Analysis
2026-05-26
Reason
Barclays
Andrew Mok
Price Target
$310 -> $304
AI Analysis
2026-05-26
downgrade
Overweight
to
Equal Weight
Reason
Barclays analyst Andrew Mok downgraded Cigna to Equal Weight from Overweight with a price target of $304, down from $310.
Barclays
Overweight
to
Equal Weight
downgrade
$310 -> $304
2026-05-26
Reason
Barclays
Price Target
$310 -> $304
2026-05-26
downgrade
Overweight
to
Equal Weight
Reason
Barclays downgraded Cigna to Equal Weight from Overweight with a price target of $304, down from $310. The company has limited potential upside to earnings estimates given its low exposure to government insurance, the analyst tells investors in a research note. The firm says Cigna also faces uncertainty from its pharmacy benefit manager transition and the pace of moderating investment spend. Barclays sees more risk than reward into the company's September investor day due to commercial attrition and AI-driven job cut risk.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CI
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cigna Group (CI.N) is 9.48, compared to its 5-year average forward P/E of 10.65. For a more detailed relative valuation and DCF analysis to assess Cigna Group's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.65
Current PE
9.48
Overvalued PE
11.83
Undervalued PE
9.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.74
Current EV/EBITDA
5.25
Overvalued EV/EBITDA
9.86
Undervalued EV/EBITDA
7.61

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.38
Current PS
0.26
Overvalued PS
0.46
Undervalued PS
0.31

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

top high conviction u.s. stocks
Intellectia · 18 candidates
Market Cap: >= 10.00BRegion: USAnalyst Consensus: Strong BuyPe Ttm: <= 25List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 15.0%Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Is Index Component: GSPC, NDX, DJI, RUTFree Cash Flow Ttm: >= 0
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
158.44B
UBER logo
UBER
Uber Technologies Inc
140.15B
NEM logo
NEM
Newmont Corporation
107.00B
RCL logo
RCL
Royal Caribbean Cruises Ltd
78.95B
CI logo
CI
Cigna Group
78.83B
B logo
B
Barrick Mining Corp
67.35B
what sector is undervalued right now
Intellectia · 90 candidates
Market Cap Category: small, mid, large, megaRelative Vol: >= 1.50Pe Ttm: <= 15Ps Ratio: <= 3.00P/B Ratio: <= 3.00Ev Ebitda: <= 12
Ticker
Name
Market Cap$
top bottom
SHEL logo
SHEL
Shell PLC
248.20B
SONY logo
SONY
Sony Group Corp
116.85B
CI logo
CI
Cigna Group
77.07B
NTES logo
NTES
NetEase Inc
72.42B
VALE logo
VALE
Vale SA
67.67B
ACGL logo
ACGL
Arch Capital Group Ltd
32.72B
top stocks in health sector
Intellectia · 38 candidates
Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
866.87B
ABBV logo
ABBV
AbbVie Inc
364.65B
AZN logo
AZN
AstraZeneca PLC
293.00B
MRK logo
MRK
Merck & Co Inc
282.35B
UNH logo
UNH
UnitedHealth Group Inc
254.55B
AMGN logo
AMGN
Amgen Inc
188.63B
give me a selection of long term stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BRevenue 5yr Cagr: >= 8Pe Ttm: 12 - 30Return On Equity: >= 13.0%Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
META logo
META
Meta Platforms Inc
1.66T
JPM logo
JPM
JPMorgan Chase & Co
775.45B
MU logo
MU
Micron Technology Inc
471.24B
MRK logo
MRK
Merck & Co Inc
287.32B
MS logo
MS
Morgan Stanley
255.47B
GS logo
GS
Goldman Sachs Group Inc
244.45B
name me one concrete stock to buy
Intellectia · 28 candidates
Market Cap: >= 10.00BRegion: USQuarter Revenue Yoy Growth: >= 10.0%Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Is Index Component: GSPCOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
DE logo
DE
Deere & Co
163.44B
FE logo
FE
FirstEnergy Corp
28.94B
CTRA logo
CTRA
Coterra Energy Inc
23.80B
MPWR logo
MPWR
Monolithic Power Systems Inc
57.06B
PKG logo
PKG
Packaging Corp of America
22.16B
HUBB logo
HUBB
Hubbell Inc
27.86B
stocks to look into tmr
Intellectia · 9 candidates
Relative Vol: >= 2Is Index Component: GSPCOne Day Rise Prob: >= 55Monthly Average Dollar Volume: >= 5,000,000
Ticker
Name
Market Cap$
top bottom
WAB logo
WAB
Westinghouse Air Brake Technologies Corp
41.66B
ROK logo
ROK
Rockwell Automation Inc
47.41B
EBAY logo
EBAY
eBay Inc
39.08B
IR logo
IR
Ingersoll Rand Inc
38.97B
KKR logo
KKR
KKR & Co Inc
91.54B
EXPE logo
EXPE
Expedia Group Inc
28.41B
which stocks should I buy?
Intellectia · 68 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
Can you add a screener for me?A I
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
insiders buying in last 30 days
Intellectia · 505 candidates
Insider Transactions: NetPurchase
Ticker
Name
Market Cap$
top bottom
GE logo
GE
General Electric Co
335.96B
LIN logo
LIN
Linde PLC
205.15B
SPGI logo
SPGI
S&P Global Inc
160.84B
ETN logo
ETN
Eaton Corporation PLC
131.26B
SBUX logo
SBUX
Starbucks Corp
109.65B
NKE logo
NKE
Nike Inc
96.83B
select 5 stocks with strong buy rating
Intellectia · 90 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong BuyPe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
RY logo
RY
Royal Bank of Canada
235.24B
ABT logo
ABT
Abbott Laboratories
209.93B
DIS logo
DIS
Walt Disney Co
202.08B
C logo
C
Citigroup Inc
198.97B

Whales Holding CI

M
Mubadala Investment Company PJSC
Holding
CI
+35.52%
3M Return
B
Bellevue Asset Management AG
Holding
CI
+19.99%
3M Return
L
Lyrical Asset Management LP
Holding
CI
+19.89%
3M Return
W
Walleye Capital LLC
Holding
CI
+19.51%
3M Return
G
Greenwich Wealth Management, LLC
Holding
CI
+18.35%
3M Return
A
Ampega Investment GmbH
Holding
CI
+16.06%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cigna Group (CI) stock price today?

The current price of CI is 286.62 USD — it has increased 1.65

What is Cigna Group (CI)'s business?

The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.

What is the price predicton of CI Stock?

Wall Street analysts forecast CI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CI is335.63 USD with a low forecast of 300.00 USD and a high forecast of 378.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cigna Group (CI)'s revenue for the last quarter?

Cigna Group revenue for the last quarter amounts to 68.49B USD, increased 4.57

What is Cigna Group (CI)'s earnings per share (EPS) for the last quarter?

Cigna Group. EPS for the last quarter amounts to 6.26 USD, increased 29.07

How many employees does Cigna Group (CI). have?

Cigna Group (CI) has 67700 emplpoyees as of July 07 2026.

What is Cigna Group (CI) market cap?

Today CI has the market capitalization of 74.59B USD.